ALNY vs FVR · P/E 76, rev $1.29B vs rev $67.1M
Alnylam Pharmaceuticals Inc (ALNY) versus FrontView REIT, Inc. (FVR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
FrontView REIT, Inc. (FVR) is a reit - diversified company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported FVR revenue for 2025-12-31 was $67.1M. Net income was -$3.8M. Revenue was up 342.2% from 2024-12-31 to 2025-12-31. FVR currently screens at market cap $281.0M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. FVR currently screens at market cap $281.0M.
Not investment advice. Open the ALNY and FVR stock pages for the full models.
Not investment advice.